BLK
BlackRock, Inc.
BLK offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
MCBS
MetroCity Bankshares, Inc.
MCBS has a slight edge over BLK overall, supported by stronger valuation and stronger modeled upside.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
MCBS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MCBS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MCBS.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
MCBS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $24.63 | -32% |
| Fair | 11x | $33.20 | -8.4% |
| Current | 12x | $36.26 | — |
| Forward | 12x | $36.26 | — |
| Expensive | 13x | $38.33 | +5.7% |
Historical ranges are pointers, not guarantees.
MCBS has the edge over BLK in the historical PE scenario, which offers more potential upside but is not a forecast.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
MCBS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect MCBS's earnings, revenue and profitability to hold roughly steady.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK earned $43.87 per share over the past year, up 11% from the year before.
MCBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.13 | +2.3% |
| Q3 2026 | $3.06 | +18% |
| Q2 2026 | $2.89 | +12% |
| Q1 2026 | $2.78 | +7.8% |
| Q4 2025 | $2.64 | +4.8% |
| Q3 2025 | $2.59 | +12% |
| Q2 2025 | $2.57 | +21% |
| Q1 2025 | $2.58 | +31% |
| Q4 2024 | $2.52 | +25% |
MCBS has the edge over BLK on earnings, with more consistent year-over-year improvement.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the edge over MCBS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK's operating margin was 30% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
MCBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $47.9M | +26% |
| Q2 2026 | $49.8M | +31% |
| Q1 2026 | $50.8M | +41% |
| Q4 2025 | $43.7M | +24% |
| Q3 2025 | $38M | +2.9% |
| Q2 2025 | $37.9M | +4.5% |
| Q1 2025 | $36M | +10% |
| Q4 2024 | $35.4M | +15% |
MCBS's revenue has grown year over year for 11 quarters in a row: $48M last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 58% | -4.4 points |
| Q2 2026 | 62% | -0.9 points |
| Q1 2026 | 59% | -1.9 points |
| Q4 2025 | 53% | -6.1 points |
| Q3 2025 | 63% | +1.4 points |
| Q2 2025 | 62% | -2 points |
| Q1 2025 | 61% | -1.3 points |
| Q4 2024 | 59% | +6.3 points |
MCBS has the edge over BLK on profitability, with a higher operating margin.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK has the edge over MCBS on cash flow, with more consistent year-over-year improvement.
MCBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.6M | -203% |
| Q2 2026 | $24.9M | +74% |
| Q1 2026 | $45.8M | +287% |
| Q4 2025 | -$5.4M | -128% |
| Q3 2025 | $16.2M | +$28M |
| Q2 2025 | $14.3M | -25% |
| Q1 2025 | $11.8M | -67% |
| Q4 2024 | $18.9M | +$28.1M |
MCBS's free cash flow was $49M over the past year, down 20% from the year before. Free cash flow isn't a meaningful measure for financial services companies like MCBS.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has the edge over MCBS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
MCBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +88K shares |
| 1 year | +12% | +3.2M shares |
| 3 years | +13% | +3.4M shares |
| 5 years | +13% | +3.3M shares |
| Available history | +17% | +4.3M shares |
MCBS has 29M diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $4.4M |
| Q4 2025 | $2.7M |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | $706,000 |
MCBS spent $7M buying back its own shares over the past year.
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has the edge over MCBS on leverage, with a lower net debt burden relative to earnings.
MCBS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 1.0x | Healthy |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.4x | Healthy |
MCBS's net debt is less than a year of its operating earnings (EBITDA), down from 2.1 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MCBS.
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
MCBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.8 | Neutral |
| Stochastic | 72.1 | Neutral |
MCBS's weekly RSI is 62 (neutral) and its Stochastic is 72 (neutral).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
MCBS PE vs Financial Services Sector
| Metric | MCBS | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 9% below |
| PE % | 69 | 63 | 6 pts above |
MCBS has the edge over BLK on valuation relative to its sector.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
BLK is in an uptrend: it's above all five of its weekly moving averages, and 33% above its 200-week average.
MCBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.4 | 2.3% above |
| 20 week MA | $35.6 | 1.8% above |
| 50 week MA | $32.3 | 12% above |
| 100 week MA | $30.4 | 19% above |
| 200 week MA | $26.9 | 35% above |
MCBS is in an uptrend: it's above all five of its weekly moving averages, and 35% above its 200-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has finished higher in five of the last six years. It's up 12% so far in 2026.
MCBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.5 | $14.3 | -18% |
| 2021 | $14.3 | $27.6 | +93% |
| 2022 | $27.6 | $21.6 | -22% |
| 2023 | $21.6 | $24.0 | +11% |
| 2024 | $24.0 | $32.0 | +33% |
| 2025 | $32.0 | $26.8 | -16% |
| 2026 YTD | $26.8 | $36.3 | +35% |
MCBS has the edge over BLK on returns for 2026, with the stronger performance.